Press Releases
Somai Pharmaceuticals announces opening of its facilities in Portugal
SOMAÍ Pharmaceuticals Unipessoal LDA has officially opened its new EU-GMP pharmaceutical facilities in Portugal, the company announced in Press release. So far, 500 kilos of cannabis have already been processed at SOMAÍ's facilities, located in Carregado, district of Lisbon. Cannareporter interviewed Michael Sassano and will publish this interview soon.
The company completed, according to the release, the first phase of the project, which encompasses 3.800 square meters of factory, independent laboratory and offices, ensuring Somaí Pharmaceuticals' prominence as the largest expandable facility for the manufacture of medical cannabis in the EU.
According to the company's statement, 500 kilos of medical cannabis have already been processed so far, in order to validate processes and prepare for the launch of products. The company's entire focus is now on delivering authorized end products to the EU market. In addition, Somai intends to set new industry standards by conducting clinical trials for absorption and in vivo for indications such as arthritis and chronic pain.
“There is great joy in providing a new cannabis production facility as more infrastructure is needed to meet growing demand in Europe and globally,” said SOMAÍ Pharmaceuticals CEO and President Michael Sassano. “SOMAÍ is creating the products of tomorrow for Europe based on the know-how current market demand and we work for patients in the largest and most competitive US markets.”
In addition to its new facilities, SOMAÍ Pharmaceuticals will run a marketing program led by an agency specializing in pharmaceutical marketing, Solaris Health. The new website of SOMAÍ is the beginning of a long-term strategy that will increase SOMAÍ's presence in the sector and highlight all upcoming product launches.
“We opened the doors of our pharmaceutical-grade facilities quickly and efficiently and are now pursuing a comprehensive marketing plan to run in parallel with our opening and product launches,” said SOMAÍ COO George Bellow.
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
I am one of the directors of CannaReporter, which I founded together with Laura Ramos. I am from the unique Island of Madeira, where I currently reside. While I was in Lisbon at FCUL studying Physical Engineering, I became involved in the national hemp and cannabis scene and participated in several associations, some of which I am still a member of. I follow the global industry and especially legislative advances regarding the different uses of cannabis.
I can be contacted by email at joao.costa@cannareporter.eu
Joana de Almeida Teixeira succeeds João Goulão as president of ICAD.
The Institute for Addictive Behaviors and Dependencies (ICAD) announced this week its new Board of Directors, which...
Czech Republic legalizes cultivation of up to 3 cannabis plants.
In the Czech Republic, adults over 21 can now cultivate up to 3 plants and possess up to 100 grams of...
SOMAÍ and Lusófona University publish peer-reviewed study confirming method for batch consistency in full-spectrum cannabis oils.
SOMAÍ, a vertically integrated multinational operator (MCO) certified by EU-GMP, specializing in cannabinoid-based medicines, in...
Portugal has already spent more than 3 million euros on Epidyolex. Infarmed has been evaluating reimbursement for almost 4 years.
The Portuguese National Health Service (SNS) has already spent over 3 million euros on the drug Epidyolex...
The endocannabinoid system can signal latent psychoses and help prevent them. CBD may be a treatment option.
A systematic review published last month in the Journal of Psychopharmacology reveals that individuals at high risk of developing...
Ghana wants to implement the “highest taxes in the world” for hemp cultivation: $45,000 per hectare.
The community interested in growing hemp and cannabis in Ghana is contesting the new licensing regime proposed by...
South Africa: Limpopo reinforces its commitment to hemp with a pilot project led by local farmers.
The Limpopo province has made progress in consolidating its position in the emerging industrial hemp sector in South Africa,...
Alexis Goosdeel ends 10-year term at EUDA: "Europe has not lost the battle"
Alexis Goosdeel, former executive director of the European Drug Administration (EUDA), has formally announced the end of his ten-year term...
Arquiconsult is hosting a webinar on validating ERP, AI, and Cloud systems in compliance with GxP on January 20th.
The increasing adoption of Artificial Intelligence (AI) and Cloud solutions is profoundly transforming highly regulated sectors, including...
Italy: Council of State accepts appeal filed by hemp-related associations.
Italian hemp producers and traders celebrated another victory this week in their long legal battle against...
